Atlas Trials

Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Clinical trial NCT05834413 · RECRUITING

Trial details

NCT number
NCT05834413
Sponsor
Shanghai University of Traditional Chinese Medicine
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Cancer
Start date
2023-05-01
Primary completion
2027-06-30
Enrollment
367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.